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ABSTRACT Transcription of mammalian genes by RNA
polymerase II often begins at a specific nucleotide, whose
location is determined either by an upstream DNA element
known as a TATA box or by an element positioned at the
transcription start site called an initiator (Inr). By in vitro
analysis of synthetic promoters, we demonstrate here that the
TATA and Inr elements are functionally similar and that the
Inr is contained between nucleotides -3 and +5 relative to the
initiation site. Moreover, we found that a mammalian tran-
scription factor LID (TFID) protein fraction is required for
transcriptional stimulation by an Spl-dependent activating
element placed upstream of either TATA or Inr elements.
However, in these assays, the yeast TATA-binding protein,
which previously was shown to function similarly to mamma-
lian TFIID, could not efficiently substitute for the mammalian
TFID fraction. These results demonstrate that mammalian
TFID is functionally distinct from the yeast TATA-binding
protein and may contain additional subunits or domains that
are important for transcriptional activation from some pro-
moters.
The regulated transcription of a typical eukaryotic gene is
governed by the combined action of multiple sequence-
specific DNA-binding proteins (1). The information provided
by these proteins is ultimately communicated to RNA poly-
merase II, resulting in a precise transcription initiation fre-
quency. In many genes, a TATA box positions the transcrip-
tion start site to a point 30 nucleotides downstream (2),
suggesting that this element plays an important role in
relaying information to RNA polymerase from factors bound
to distal control elements. A chromatographic fraction
termed transcription factor IID (TFIID) that stimulates tran-
scription initiation (3, 4) and contains a DNA-binding activity
that specifically interacts with TATA sequences (5) has been
derived from mammalian (6) and Drosophila (7) cells. A
protein with similar activities has been identified in yeast (8)
and the gene encoding this yeast TATA-binding protein
(referred to as yeast TFIID) has been isolated (9-13).
Recently, it was shown that no TATA elements are found
in either the small nuclearRNA (snRNA) genes or the murine
terminal deoxynucleotidyltransferase (TdT) gene, but that
distinct elements determine the precise transcription start
sites. For snRNA genes, an element located =60 nucleotides
from the start site is crucial for promoter function and start
site placement (14). TdT transcription requires an initiator
(Inr) element (15-17) that directly overlaps the start site and
exhibits sequence homology to start-site regions for other
polymerase II-transcribed genes. In vitro experiments as-
cribed two distinct activities to an Inr (15): (i) the ability to
independently direct RNA polymerase II to initiate transcrip-
tion from a specific, internal position; and (ii) the ability to be
activated in the absence of TATA by an upstream activator
element, resulting in high levels of accurate transcription.
In this paper, we describe further characterization of an
Inr, beginning with a direct comparison of the effects of Inr
and TATA on the functioning of a transcription factor Spl-
dependent upstream activator element. We also describe the
activities ofa series of Inr mutants and have begun to address
the protein requirements for Inr-mediated transcription.
MATERIALS AND METHODS
Plasmid DNAs. The plasmids designated I-VII (see Fig. 1
Lower) are similar to plasmids described previously (15).
They contain oligonucleotides for the TdT Inr or the aden-
ovirus major late (AdML) promoter TATA box, or a restric-
tion fragment containing the simian virus 40 (SV40) 21-
base-pair (bp) repeats (15), inserted into the pSP72 (Promega)
polylinker. Plasmid I was called TdTl7mer(pSP72), plasmid
II contains theTATA oligonucleotide in the pSP72 EcoRI and
Sac I sites, plasmid III contains the 21-bp repeats in the
pSP72 Bgl II site as in the previously described pSpl 42 Inr
(but without the Inr oligonucleotide), plasmid IV was called
TATA/17mer(pSP72), plasmid V contains the 21-bp repeats
as in plasmid III plus the TATA oligonucleotide as in plasmid
II, plasmid VI was called pSP1 42 Inr, and plasmid VII
contains the TATA oligonucleotide in the EcoRI and Sac I
sites of pSP1 42 Inr.
Plasmids containing Inr mutations were constructed with
synthetic oligonucleotides, which were inserted into the Sac
I and BamHI sites of pUC18 for Inr-only transcription, and
into plasmid III for Spl-Inr transcription. All plasmids were
purified twice on CsCl equilibrium gradients (18).
In Vitro Transcription. Nuclear extracts were prepared
from HeLa cells as described (15, 19, 20). Selective heat
inactivation ofTFIID at 470C was by the method ofNakajima
et al. (6). Nuclear extracts were depleted of TFIID by
chromatography on phosphocellulose (21).
HeLa TFIID (0.6 mg of protein per ml) was prepared by
chromatography on phosphocellulose and DEAE-cellulose
as described (21). The FPLC Mono S column was prepared
with a nuclear extract from RLm11 T cells that had first been
applied to a heparin-agarose column and eluted with a 0.2-0.4
M KCI step. This fraction (4 mg) was loaded onto a 1-ml
Mono S column in 25 mM Hepes, pH 7.9/10% (vol/vol)
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glycerol/0.2 mM EDTA/1 mM dithiothreitol/100 mM KCl.
The column was washed with 5 ml of loading buffer and
eluted at 0.4 ml/min with a 20-ml linear KCI gradient (0.1-0.5
M). One-milliliter fractions were collected.
YeastTFIID was purified (21) or overexpressed in Esch-
erichia coli prepared as described (11).
In vitro transcription reactions were performed as de-
scribed (15, 22), with 10 tLI of crude or heat-inactivated
extract (20 mg/ml) containing appropriate fractions. Primer
extension was performed as described (15,23). We confirmed
all results from plasmid I with S1 nuclease analysis (data not
shown; see ref. 15). The signals from S1 nuclease experi-
ments are extremely weak, but the results are more consis-
tent and eliminate difficulties arising from incomplete reverse
transcription.
RESULTS
Comparison of TATA andInr. We inserted into a plasmid
vector, in various combinations, oligonucleotides containing
TATA or Inr elements, as well as in some constructs a
restriction fragment containing an upstream activator ele-
ment, the SV40 21-bp repeats [containing six binding sites for
transcription factor Spl (24)]. The plasmids, labeled with
roman numerals in Fig. 1, were tested for promoter activity
by in vitro transcription and primer-extension analysis. Con-
sistent with previous findings by us (15) or others (2, 25, 26),
plasmids containing the isolated Inr (plasmid I), TATA
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FIG. 1. In vitro transcription from synthetic promoters. Oligo-
nucleotides containing either the AdML TATA or TdT Inr, or a
fragment containing the SV40 21-bp repeats, were inserted into
plasmid pSP72 (see Materials and Methods and ref. 15). Distances
between the 21-bp repeats and TATA or Inr were varied to obtain
maximal signals (15). The distance between TATA and Inr is 27 bp,
the distance between the 21-bp repeats and Inr is 42 bp, and the
distance between the 21-bp repeats and TATA is 30 bp. In vitro
transcription reactions were performed in HeLa nuclear extracts
with 100 ng (Upper Left) or 400 ng (Upper Right) of supercoiled
template. RNA was analyzed by primer extension with a SP6
promoter primer (Promega) and electrophoresed on an 8% denatur-
ing polyacrylamide gel. The dried gel was exposed for 2 hr with an
intensifying screen. Sizes of extension products were 79 nucleotides
(lanes I, IV, VI, and VII) or 70 nucleotides (lanes II and V), as
indicated. The promoters used for each reaction are diagrammed at
the bottom.
(plasmid II), or upstream activator (plasmid III) promoted
transcription initiation, but at a very low frequency. With 400
ng of DNA (Fig. 1 Upper Right), accurate initiation was
detected from within the Inr (lane I) or from heterogeneous
nucleotides downstream of the 21-bp repeats (lane III). A
signal was not detected from plasmid II with the exposure
shown here (lane II) but was visible with longer exposures
(see Fig. 3A, lane 1). With 100 ng of template, these signals
were weaker (Fig. 1 Upper Left, lanes I, II, and III). When
TATA was positioned 30 bp upstream of the Inr (plasmid IV),
promoter strength increased but remained relatively weak
with either 100 or 400 ng of DNA (Fig. 1 Upper, lanes IV). To
obtain high levels of transcription, the 21-bp repeats had to be
positioned upstream of either TATA or Inr. With a promoter
containing the 21-bp repeats and TATA (plasmid V), efficient
transcription began 30 bp downstream from TATA (lanes V).
This promoter strength varied by only 3-fold as the 21-bp
repeats were moved from 12 to 60 bp upstream ofTATA (data
not shown). With a promoter containing the 21-bp repeats
and Inr (plasmid VI), equally strong transcription began from
within the Inr (lanes VI). The variability of promoter strength
with distance between the 21-bp repeats and Inr has been
reported (15). When both TATA and Inr were downstream of
the 21-bp repeats (plasmid VII), with TATA appropriately
positioned 30 bp from Inr, promoter strength increased by
another 3- to 5-fold (lanes VII). These results demonstrate
that either an Inr or a TATA box is sufficient to allow the
21-bp repeats to activate transcription efficiently and with
site specificity.
Analysis of Inr Mutants. Mutant Inr elements were pre-
pared and tested for two activities in nuclear extracts: (i) the
ability to direct transcription independently; and (ii) the
ability to direct high levels of accurate transcription in the
presence of the 21-bp repeats. One set of mutants contains
substitutions in the central region of the Inr and are called C1,
C2, C3, and C4 (Fig. 2). In crude extracts, C4 behaved like
the wild-type Inr (lanes 5 and 15), but C1, C2, and C3 impeded
both independent Inr transcription (lanes 2-4) and Inr acti-
vation by the 21-bp repeats (Fig. 2, lanes 12-14, bottom). The
effects of the mutations on transcription mediated by the
21-bp repeats became even greater when the mutants were
tested in a competition assay with plasmid V, which was
added to each reaction mixture in equimolar amounts (Fig. 2,
lanes 12-14, top). Interestingly, mutant C2 altered the start
site to the G that was placed at the -1 position.
A second set of mutants, F1, F2, and F3, contained
substitutions in the flanking regions of the Inr. These muta-
tions had little effect on transcription in the absence of the
21-bp repeats (Fig. 2, lanes 7-9). However, F1 and F3, which
both alter nucleotides +3 to +5, only directed low levels of
transcription when the 21-bp repeats were present (Fig. 2,
lanes 18 and 20: top, with competitor; bottom, without
competitor). We previously showed that a mutation at nu-
cleotides -2 and -3 strongly diminished Inr transcription
and that aT to C transition at nucleotide +2 had no effect (15).
Taken together, these data show that the functional TdT Inr
is contained within ":8 bp, from -3 to +5 (Fig. 2 Lower).
Requirement for Mammalian 1TIID. TATA-mediated tran-
scription requires recognition of the TATA box by a DNA-
binding protein, TFIID (3-7). Because we detected efficient
transcription in the absence of TATA and in the presence of
Spi and Inr sites, it was important to determine whether this
transcription required TFIID. To test for the TFIID require-
ment, we made use of the observation that TFIID activity can
be depleted selectively from HeLa nuclear extracts by mild
heat treatment (6). With templates II, IV, V, or VI, tran-
scription was abolished by this heat treatment (Fig. 3A, lanes
2, 5, 8, and 11). More importantly, efficient transcription was
recovered in all cases by addition of partially purified HeLa
TFIID (21) (lanes 3, 6, 9, and 12) that is known to lack RNA
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FIG. 3. HeLa TFIID requirement for TATA-
and Inr-mediated transcription. In vitro transcrip-
tions were assayed by primer extension as de-
scribed in Fig. 1. (A) Transcription reactions were
performed with 200 ng ofplasmids II (lanes 1-3), IV
(lanes 4-6), VI (lanes 7-9), and V (lanes 10-12),
using 200 mg of crude nuclear extract (lanes 1, 4, 7,
and 10), heat-inactivated extract (to deplete TFIID;
lanes 2, 5, 8, and 11), or heat-inactivated extract
supplemented with 2 Al of partially purified HeLa
TFIID (lanes 3, 6, 9, and 12). Short (top lanes) and
long (bottom lanes) exposures of the gel are shown,
and the template and expected size of extension
product for that template are indicated at the bot-
tom. The arrows indicate the locations of the 70-
and 79-bp products. (B) One hundred nanograms of
plasmids VI (79-bp extension) and V (70-bp exten-
sion) were mixed and tested as described above,
using crude extract (lane 1), heat-inactivated ex-
tract (lane 2), or heat-inactivated extract with 1
(lane 3), 2 (lane 4), or 4 (lane 5) Al of HeLa TFIID.
(C) One hundred nanograms of plasmids VI and V
were assayed with heat-inactivated extract supple-
mented with 10 p.l of column fraction from FPLC
Mono S column. Fraction number and the begin-
ning and ending KCI concentration from the linear
salt gradient are indicated.
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yeast TFIID expressed in E. coli failed to stimulate transcrip-
tion in heat-inactivated HeLa extracts (Fig. 4, lanes 7-9). A
similar result was found with authentic, purified yeast TFIID
and with HeLa extracts depleted of mammalian TFIID by
column chromatography (data not shown). This result could be
due to the inability of yeast TFIID to mediate an interaction
with either the 21-bp repeats or the Inr; the following results
suggest that both interactions may be defective.
First, yeast TFIID was defective in its response to an Inr
element. An Inr typically had a 10-fold effect on transcription
directed by TATA in the presence of HeLa TFIID, as shown
in Fig. 5A (Right) by comparing transcription of plasmids IV
and II. By contrast, in the presence of yeast TFIID, the
promoter strengths of plasmids IV and II were identical (Fig.
5A Left).
Moreover, yeast TFIID was defective in its response to the
SV40 21-bp repeats. Yeast TFIID strongly activated tran-
scription from TATA-containing constructs, but the presence
of the 21-bp repeats had only a 3- to 5-fold effect (Fig. 4,
compare lanes 3 and 12). Even though enough yeast protein
was added for efficient transcription from plasmid II (lane 3),
it could not restore plasmid V transcription to the level seen
in crude extract (Fig. 4, compare lanes 10 and 12). This result
is very different from that observed in Fig. 3A, where much
less HeLa TFIID activity (as determined with plasmid II;
compare Fig. 3A, lane 3, to Fig. 4, lane 3) completely restored
plasmid V transcription (compare Fig. 3A, lanes 10 and 12, to
Fig. 4, lanes 10 and 12).
A more complete deficiency in Spl responsiveness was
observed when authentic, purified yeast TFIID was added to
extracts depleted of HeLa TFIID by phosphocellulose chro-
matography (Fig. 5B). In this case, addition of yeast protein
with plasmids II (lanes 1-3 and 7-9) and V (lanes 4-6 and
10-12) showed no effect of the Spl sites. This result was
observed with either 100 (lanes 1-6) or 2000 (lanes 7-12) ng
of template DNA. This is in contrast to the addition of HeLa
TFIID, which resulted in a 10-fold stimulation by the 21-bp
repeats (data not shown). The results also differ from exper-
iments reported previously by two ofus (21) and expanded on
in Fig. SB, with adenovirus E1B promoter plasmids. By
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FIG. 4. Yeast TFIID requirement for TATA- and Inr-mediated
transcription. This experiment was performed exactly as in Fig. 3A,
except reactions in lanes 3, 6, 9, and 12 were supplemented with 8 Ul
of partially purified yeast TATA-binding protein expressed in E. coli
(see Materials and Methods). Similar results were found with
authentic, purified yeast TATA-binding protein (data not shown).
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FIG. 5. Yeast TFIID activity on synthetic and adenovirus E1B
promoters. (A) Two hundred nanograms each of plasmids II and IV
were mixed and assayed with 200 mg of heat-inactivated extract and
either 2 or 4 A.l of yeast TFIID (Left) or 2 fl of HeLa TFIID (Right).
Arrows indicate sizes of expected products for plasmid IV (79 bp) or
plasmid 11 (70 bp). (B) A HeLa crude extract was depleted of TFIID
by fractionation on phosphocellulose (see Materials and Methods).
In vitro reactions were performed with 3 A.l of 0.1-0.6 M KCI
phosphocellulose step, containing 0 (lanes 1, 4, 7, 10, 13, 16, 19, and
22), 1 (lanes 2, 5, 8, 11, 14, 17, 20, and 23), or 4 (lanes 3, 6, 9, 12, 15,
18, 21, and 24) Al of a 1:5 dilution of purified yeast TFIID. The
template DNAs were either plasmid II (lanes 1-3 and 7-9) compared
with plasmid V (lanes 4-6 and 10-12) or the wild-type E1B promoter
plasmid pAd1B (lanes 16-18 and 22-24) compared with a mutation in
the Spl site of the E1B promoter (plasmid LS-48/-39; lanes 13-15 and
19-21). The E1B plasmids have been described (21). Either 100 ng
(lanes 1-6 and 13-18) or 2000 ng (lanes 7-12 and 19-24) of plasmid
DNA was used in each reaction. Primer extensions were performed
with the SP6 primer (lanes 1-12) or primer B1750 (see ref. 21; lanes
13-24). Extension products were 70 bp (lanes 1-12) or 52 bp (lanes
13-24). All reactions in this figure were performed at the same time.
comparing the wild-type promoter (pAd1B) containing a
TATA box and a single Spl site with a mutant promoter
(LS-48/-39) containing a mutation in the Spl site, a strong
stimulation by the Spl site was observed with yeast TFIID
(Fig. SB, compare lanes 19-21 with lanes 22-24). Interest-
ingly, this strong effect was only observed with high DNA
concentrations (lanes 19-24) and not with low concentrations
(lanes 13-18).
DISCUSSION
It is evident that either a TATA box or an Inr element is
necessary for the SV40 21-bp repeats to direct efficient and
accurate transcription in vitro. This result demonstrates that
TATA and Inr carry out a similar function during transcrip-
tion initiation. However, because TATA is located 30 bp
upstream of the transcription start site, while an Inr directly
overlaps the start site, it is unlikely that these two elements
carry out this function by identical mechanisms.
The mutational analyses reported here (Fig. 2) and previ-
ously (15) reveal that the TdT Inr extends from approxi-
4512 Biochemistry: Smale et al.
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mately nucleotide -3 to +5. Within this region, nucleotide
+2 appears to be unnecessary because complete Inr function
is found with a T, G (mutant C4), or C (AdML Inr; ref. 15)
at this position. It is noteworthy that the inactive mutant C1
contains the start site sequence for the TATA-containing
human immunodeficiency virus type 1 (HIV-1) gene, which
exhibits a 5 of 8 nucleotide homology with the TdT Inr
(nucleotides -3 to +5). Although the HIV start-site region
appears nonfunctional in our assay, previous mutagenesis of
the HIV promoter suggested a role for this region in HIV
transcription (27). Further analysis will be required to deter-
mine whether this homology is fortuitous or whether this HIV
Inr is functional only in the context of the specific array of
HIV control elements that have been identified both imme-
diately upstream and downstream of the transcription start
site (27-29).
In beginning to define the proteins involved in Spl/Inr
transcription, we have found a requirement for mammalian
TFIID, which previously was defined as a crude protein
fraction required for transcription initiation (3, 4) and con-
taining a TATA-binding activity (5). The TFIID requirement
in the absence of a TATA box is consistent with studies of the
adenovirus IVa2 gene (30), although it is not yet clear what
element replaces TATA in this adenovirus promoter. The
activities in the TFIID fraction that stimulate both Spl/
TATA and Spl/Inr transcription are likely to be carried out
by the same protein or protein complex because of two
observations: (i) the two activities copurify through three
columns and, most importantly, across a gradient elution
from a high-resolution FPLC Mono S column; and (ii) both
activities are unusually heat sensitive. However, because the
mammalian TFIID fraction has not been purified to homo-
geneity, we cannot rule out the possibility that this fraction
contains two distinct, heat-sensitive proteins that stimulate
TATA- or Inr-mediated transcription.
The observation that yeast TATA-binding protein cannot
effectively substitute for mammalian TFIID may provide
insight into the structure and function of mammalian TFIID.
The clearest deficiency of the yeast protein is its inability to
stimulate transcription mediated by an Inr, as is evident from
experiments with plasmids VI (Spl/Inr) and IV (TATA/Inr).
If the same protein in the mammalian TFIID fraction stimu-
lates transcription from both TATA- and Inr-containing plas-
mids, then yeast TFIID may contain domains that are signif-
icantly diverged from HeLa TFIID such that they cannot
mediate interactions required for transcription from an Inr.
Alternatively, the yeast protein may lack additional domains
or subunits that are found in mammalian TFIID. We favor this
second possibility because (i) mammalian TFIID chromato-
graphs as a much larger protein than the 27-kDa yeast TFIID
(31), and (ii) DNase I footprinting analysis with partially
purified mammalian TFIID shows more extensive protection
of some promoters (6) than does yeast TFIID. In fact, because
HeLa TFIID has been shown to protect from DNase digestion
the start-site region of the Inr-containing AdML promoter, but
not the start-site regions for several Inr-lacking promoters (6),
HeLa TFIID may contain the polypeptide that interacts with
the Inr. We do not yet know whether this putative, additional
subunit is absent in yeast or whether it simply does not
copurify with the yeast TATA-binding protein.
While analyzing the protein requirements for Inr-mediated
transcription, we found that yeast TFIID could not activate
transcription of our control plasmid V, containing the 21-bp
repeats 30 bp upstream of a TATA box. This deficiency is
difficult to interpret because the results vary depending on
which plasmid template is used. Clearly, transcription from
the adenovirus E1B promoter, containing a single Spi binding
site 8 bp from the TATA box, responds well, although the Spi
response is observed only at high template concentrations.
Two differences between these two plasmids are (i) the
distances between the Spl site and TATA box, and (ii) the
number of SP1 binding sites. Neither of these differences is
important, however, because a promoter containing two con-
sensus Spl binding sites 30 bp from the E1B TATA box also
responds well to the Spl sites in the presence of yeast TFIID
(M.C.S., R. Segal, and A.J.B., unpublished results). Further
experiments are necessary to determine the relevant differ-
ences between the two templates and to explain the template
concentration dependence of the E1B promoter response.
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